Assignee
MOUSA SHAKER A
US·24 granted patents·5 pending applications·211 citations·filing 2004–2023
Top patents by PatentIndex Score
29 records- 0198US8668926B1Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereofMOUSA SHAKER A·Filed 2007·Granted Mar 11, 2014·95 cites·6 claims
- 0296US8071134B2Thyroid hormone analogs and methods of useMOUSA SHAKER A·Filed 2005·Granted Dec 6, 2011·27 cites·4 claims
- 0394US9198887B2Thyroid hormone analogs and methods of useMOUSA SHAKER A·Filed 2013·Granted Dec 1, 2015·16 cites·6 claims
- 0493US8518451B2Thyroid hormone analogs and methods of useMOUSA SHAKER A·Filed 2009·Granted Aug 27, 2013·21 cites·3 claims
- 0591US8481479B1Formulations of factor VIIa inhibitors and utilityMOUSA SHAKER A·Filed 2012·Granted Jul 9, 2013·10 cites·7 claims
- 0690US8071569B2Oxidized heparin fractions and their use in inhibiting angiogenesisMOUSA SHAKER A·Filed 2011·Granted Dec 6, 2011·15 cites·19 claims
- 0786US9655862B2Ocular nanoformulation and method of use in angiogenesis-mediated disordersMOUSA SHAKER A·Filed 2014·Granted May 23, 2017·3 cites·24 claims
- 0884US8563053B2Compositions and methods of natural products in nanoformulations for the prevention and treatment of osteoporosisMOUSA SHAKER A·Filed 2010·Granted Oct 22, 2013·7 cites·22 claims
- 0979US8968790B2Nanoformulation of vitamin D derivatives and/or vitamin D metabolitesMOUSA SHAKER A·Filed 2012·Granted Mar 3, 2015·9 cites·27 claims
- 1078US10046005B2Composition and method of use for combinations of anti-viral protease, polymerase inhibitors and natural bioactive compounds in the treatment of hepatitis C infectionMOUSA SHAKER A·Filed 2016·Granted Aug 14, 2018·1 cites·18 claims
- 1177US9956291B2Nanoformulation and methods of use of thyroid receptor beta1 agonists for liver targetingMOUSA SHAKER A·Filed 2013·Granted May 1, 2018·1 cites·20 claims
- 1277US8980823B2Formulations of Factor VIIa inhibitors and utilityMOUSA SHAKER A·Filed 2013·Granted Mar 17, 2015·1 cites·22 claims
- 1376US9822190B2Compositions and method for anti-sickling of red blood cells in sickle cell diseaseMOUSA SHAKER A·Filed 2016·Granted Nov 21, 2017·1 cites·19 claims
- 1475US8314078B2Silver nanoparticles as anti-microbialMOUSA SHAKER A·Filed 2010·Granted Nov 20, 2012·3 cites·20 claims
- 1567US9480703B2Method and composition of glycosaminoglycans in sickle cell and vascular disordersMOUSA SHAKER A·Filed 2014·Granted Nov 1, 2016·0 cites·20 claims
- 1666US2023414556A1Nano-hepatic targeted epigallocatechin gallate in dyslipidemiaMOUSA SHAKER A·Filed 2023·Application pending·0 cites
- 1763US9770419B2Methods and compositions of camel derived productsMOUSA SHAKER A·Filed 2013·Granted Sep 26, 2017·1 cites·17 claims
- 1860US9980933B2Thyroid hormone analogs and methods of useMOUSA SHAKER A·Filed 2013·Granted May 29, 2018·0 cites·10 claims
- 1958US9572831B2Composition and method for sulfated non-anticoagulant low molecular weight heparins in cancer and tumor metastasisMOUSA SHAKER A·Filed 2014·Granted Feb 21, 2017·0 cites·18 claims
- 2058US2006104944A1Activators and inhibitors of protease activated receptor2 (PAR2) and methods of useMOUSA SHAKER A·Filed 2004·Application pending·0 cites
- 2157US2009022806A1Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists and formulations and uses thereofMOUSA SHAKER A·Filed 2007·Application pending·0 cites
- 2253US9597351B2Nano-targeted delivery of protease, polymerase inhibitors with or without immune modulators in the treatment of hepatitis CMOUSA SHAKER A·Filed 2015·Granted Mar 21, 2017·0 cites·21 claims
- 2351US9956181B2Composition of nanoformulated lycopene and method of using the compositionMOUSA SHAKER A·Filed 2016·Granted May 1, 2018·0 cites·15 claims
- 2451US8859539B2Compositions of dual thyrointegrin antagonists and use in vascular-associated disordersMOUSA SHAKER A·Filed 2010·Granted Oct 14, 2014·0 cites·3 claims
- 2543US2016338971A1Nano co-encapsulation for the prevention and treatment of various disordersMOUSA SHAKER A·Filed 2016·Application pending·0 cites
- 2642US8607989B2Filter composites for drug detoxificationMOUSA SHAKER A·Filed 2010·Granted Dec 17, 2013·0 cites·24 claims
- 2741US9700042B2Nanoformulation of musk-derived bioactive ingredients for nanocosmetic applicationsMOUSA SHAKER A·Filed 2015·Granted Jul 11, 2017·0 cites·8 claims
- 2840US9707318B2Compositions of novel bone patch in bone and vascular regenerationMOUSA SHAKER A·Filed 2010·Granted Jul 18, 2017·0 cites·7 claims
- 2939US2011104265A1Compositions and methods of targeted nanoformulations in the management of osteoporosisMOUSA SHAKER A·Filed 2010·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →